Knowing that FHL2 levels are different in different cancer types, we analyzed a dataset (GSE103512) containing four different cancer samples, our analysis revealed that colon cancer and prostate cancer had similar levels of FHL2 expression while breast cancer and non-small cell lung cancer had significantly lower levels of FHL2 expression than colon cancer and prostate cancer (Fig. S2). The gene discussed is FHL2; the disease is prostate carcinoma.